Analysis of quality improvement efforts in preventing glucocorticoid-induced osteoporosis

Seminars in Arthritis and Rheumatism

Volumn 44, Issue 5, 2015, Pages 483-488

  Tory, Heather O ^a,b   Solomon, Daniel H ^b   Desai, Sonali P ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Glucocorticoids; Osteoporosis; Quality of care

Indexed keywords

CALCITRIOL; CALCIUM CARBONATE; GLUCOCORTICOID; PREDNISONE; VITAMIN D;

BONE MINERAL; CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; CORTICOSTEROID INDUCED OSTEOPOROSIS; DESCRIPTIVE RESEARCH; DRUG DOSE REDUCTION; HEALTH CARE QUALITY; HORMONE SUBSTITUTION; HUMAN; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; VITAMIN DEFICIENCY; CHEMICALLY INDUCED; OSTEOPOROSIS;

GLUCOCORTICOIDS; HUMANS; OSTEOPOROSIS; QUALITY IMPROVEMENT; QUALITY OF HEALTH CARE;

EID: 84926342973     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2014.09.011     Document Type: Review

References (28)

1. Schacke H., Docke W.D., Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 2002, 96:23-43.
2. Saag K.G. Glucocorticoid use in rheumatoid arthritis. Curr Rheumatol Rep 2002, 4:218-225.
3. van Staa T.P., Geusens P., Pols H.A., de Laet C., Leufkens H.G., Cooper C. A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM 2005, 98:191-198.
4. Weinstein R.S. Glucocorticoid-induced bone disease. N Engl J Med 2011, 365:62-70.
5. den Uyl D., Bultink I.E., Lems W.F. Advances in glucocorticoid-induced osteoporosis. Curr Rheumatol Rep 2011, 13:233-240.
6. Lems W.F. Bisphosphonates and glucocorticoids: effects on bone quality. Arthritis Rheum 2007, 56:3518-3522.
7. Van Staa T.P., Laan R.F., Barton I.P., Cohen S., Reid D.M., Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 2003, 48:3224-3229.
8. Grossman J.M., Gordon R., Ranganath V.K., Deal C., Caplan L., Chen W., et al. American college of rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 2010, 62:1515-1526.
9. Majumdar S.R., Lix L.M., Yogendran M., Morin S.N., Metge C.J., Leslie W.D. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008). J Clin Endocrinol Metab 2012, 97:1236-1242.
10. McKeown E, Bykerk VP, De Leon F, Bonner A, Thorne C, Hitchon CA, et al. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort. Rheumatology (Oxford) 2012;51:1662-9.
11. Curtis J.R., Westfall A.O., Allison J., Becker A., Melton M.E., Freeman A., et al. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial. Arch Intern Med 2007, 167:591-596.
12. Saag K.G., Gehlbach S.H., Curtis J.R., Youket T.E., Worley K., Lange J.L. Trends in prevention of glucocorticoid-induced osteoporosis. J Rheumatol 2006, 33:1651-1657.
13. Ledwich L.J., Clarke K. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice. J Clin Rheumatol 2009, 15:61-64.
14. Mohammad A., Ryan J.G., Ralph N., Ryan C., O'Connell P.G. Improving trends in glucocorticoid-induced osteoporosis management: 2002 to 2006. Clin Exp Rheumatol 2007, 25:728-733.
15. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269.
16. Kohler M.J., Amezaga M., Drozd J., Crowley S.T., Gulanski B., Anderson D.R., et al. Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids. J Gen Intern Med 2013, 28:825-829.
17. Newman E.D., Matzko C.K., Olenginski T.P., Perruquet J.L., Harrington T.M., Maloney-Saxon G., et al. Glucocorticoid-induced osteoporosis program (GIOP): a novel, comprehensive, and highly successful care program with improved outcomes at 1 year. Osteoporos Int 2006, 17:1428-1434.
18. Solomon D.H., Katz J.N., La Tourette A.M., Coblyn J.S. Multifaceted intervention to improve rheumatologists' management of glucocorticoid-induced osteoporosis: a randomized controlled trial. Arthritis Rheum 2004, 51:383-387.
19. Chitre M.M., Hayes W. 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan. J Manag Care Pharm 2008, 14:281-290.
20. Naunton M., Peterson G.M., Jones G., Griffin G.M., Bleasel M.D. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis. J Rheumatol 2004, 31:550-556.
21. McDonough R.P., Doucette W.R., Kumbera P., Klepser D.G. An evaluation of managing and educating patients on the risk of glucocorticoid-induced osteoporosis. Value Health 2005, 8:24-31.
22. Egger M., Ebrahim S., Smith G.D. Where now for meta-analysis?. Int J Epidemiol 2002, 31:1-5.
23. Physician consortium for performance improvement/national committee for quality assurance: osteoporosis measure #6. Accessed 30.05.14. http://www.aaos.org/research/committee/evidence/pcpi_measures_osteoporosis.pdf.
24. National quality forum. Osteopenia and chronic steroid use-treatment to prevent osteoporosis. Accessed 30.05.14. http://www.qualityforum.org/.
25. Curtis J.R., Arora T., Xi J., Silver A., Allison J.J., Chen L., et al. Do physicians within the same practice setting manage osteoporosis patients similarly? Implications for implementation research. Osteoporos Int 2009, 20:1921-1927.
26. Institute of Medicine (U.S.).Committee on Quality of Health Care in America Crossing the quality chasm: a new health system for the 21st century 2001, National Academy Press, Washington, DC.
27. Solomon D.H., Katz J.N., Jacobs J.P., La Tourette A.M., Coblyn J. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 2002, 46:3136-3142.
28. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.